Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01194362 · ClinicalTrials.gov registry record
A Study to Identify Differences in Gene Expression in Patients With Bicuspid and Tricuspid Valve Disease
A clinical trial, sponsored by Baylor Research Institute.
- Completed
- Registry status
- 91
- Enrollment target
NCT01194362: Completed study, sponsored by Baylor Research Institute.
NCT01194362 is a clinical trial that has completed, run by Baylor Research Institute. The registered enrollment target is 91 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01194362 has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- 91 participants
- Enrollment target
Study Summary
For this study, blood and tissue samples will be collected in order to perform genetic testing to help researchers gather information about this disease and how and why it affects some patients more than others.
Primary Outcome
Determine differences in genetic expression profiles using mRNA transcriptional analysis in the three groups: subjects with bicuspid aortic valves with aortic stenosis, subjects with tricuspid aortic valves with stenosis, and subjects without aortic valve disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2010-06-20 |
| Est. Completion | 2022-09-23 |
What the finished NCT01194362 record still lists
NCT01194362 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 91 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01194362 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01194362 about?
NCT01194362 is a clinical study titled "A Study to Identify Differences in Gene Expression in Patients With Bicuspid and Tricuspid Valve Disease". For this study, blood and tissue samples will be collected in order to perform genetic testing to help researchers gather information about this disease and how and why it affects some patients more than others.
What is the current status of trial NCT01194362?
This trial is currently completed. The enrollment target is 91 participants. The study started on 2010-06-20. Estimated completion is 2022-09-23.
Who is sponsoring clinical trial NCT01194362?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02671448 · 91 participants · NA
Pilot Trial of Homebound Stem Cell Transplantation
- NCT04835857 · 91 participants
Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices
- NCT05184842 · 91 participants · Phase 2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- NCT05685173 · 91 participants · Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI